Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Resource Support drink
090402000BBQNA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Resource Thickened Squash custard
191300000BMCEA0
|
Proprietary compound preparation BNF 1913000 | Other cordial/soft drink preparations | Other Drugs and Preparations | No data available |
|
Resource Thickened Squash syrup
191300000BMCDA0
|
Proprietary compound preparation BNF 1913000 | Other cordial/soft drink preparations | Other Drugs and Preparations | No data available |
|
RESPeRATE device
21440000100
|
RESPeRATE device | Devices for Adjunctive Treatment of Hypertension | Appliances | No data available |
|
Respillin 250mg capsules
0501013B0BNACAA
|
Respillin | Amoxicillin | Infections | No data available |
|
Respillin 500mg capsules
0501013B0BNADAB
|
Respillin | Amoxicillin | Infections | No data available |
|
Restandol 40mg capsules
0604020T0BBAAAA
|
Restandol | Testosterone undecanoate | Endocrine System | No data available |
|
Restasis 0.05% eye drops 0.4ml unit dose
1104020AEBEAAAJ
|
Restasis | Ciclosporin (Eye Anti Inflammatory) | Eye | No data available |
|
Retacrit 1,000units/0.3ml inj pre-filled syringes
0901030Q0BBAAAA
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 2,000units/0.6ml inj pre-filled syringes
0901030Q0BBABAB
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 20,000units/0.5ml inj pre-filled syringes
0901030Q0BBAJAJ
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 3,000units/0.9ml inj pre-filled syringes
0901030Q0BBACAC
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 4,000units/0.4ml inj pre-filled syringes
0901030Q0BBADAD
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 40,000units/1ml inj pre-filled syringes
0901030Q0BBAIAI
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 5,000units/0.5ml inj pre-filled syringes
0901030Q0BBAEAE
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 6,000units/0.6ml inj pre-filled syringes
0901030Q0BBAFAF
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 8,000units/0.8ml inj pre-filled syringes
0901030Q0BBAGAG
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retapamulin 1% ointment
1310011AAAAAAAA
|
Retapamulin | Retapamulin | Skin | No data available |
|
Retenere Food Supplement tablets
0913472A0BCAAAB
|
Retenere tablets/capsules micronutrient supplement | Tabs/Caps OTC cond specific vitamin & mineral supp (0913472) | Nutrition and Blood | No data available |
|
Retention ring 25mm
21180000092
|
Retention ring 25mm | Erectile Dysfunction Devices | Appliances | No data available |
|
Retention ring 25mm/32mm/40mm
21180000095
|
Retention ring 25mm/32mm/40mm | Erectile Dysfunction Devices | Appliances | No data available |
|
Retention ring 32mm
21180000093
|
Retention ring 32mm | Erectile Dysfunction Devices | Appliances | No data available |
|
Retention ring 40mm
21180000094
|
Retention ring 40mm | Erectile Dysfunction Devices | Appliances | No data available |
|
Reteplase 10unit inj vials
0210020K0AAAAAA
|
Reteplase | Reteplase | Cardiovascular System | No data available |
|
Retigabine 100mg tablets
0408010AJAAAAAA
|
Retigabine | Retigabine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.